Building Resilient Pharma / Biotech Facilities & Quality Systems

ABOUT THE CONFERENCE

PharmaXcelerate 2026 is the leading regional platform dedicated to advancing excellence in pharmaceutical and biotech manufacturing, quality, and facility design. Taking place from 18 – 20 January 2026 in Dubai, UAE, the summit will unite senior executives, manufacturing and quality leaders, regulators, and solution providers driving the future of compliant and efficient pharma production across the Middle East and beyond.

The event is structured around three core pillars: Engineering & Facility Design, highlighting digital transformation, cleanroom innovation, and sustainable operations; Manufacturing Excellence, focused on process optimization, technology transfer, and operational agility; and Quality & Compliance, addressing GMP readiness, validation, and sterile manufacturing best practices.

PharmaXcelerate will feature senior representatives from global leaders such as Pfizer, AstraZeneca, Sanofi, GSK, Roche, Johnson & Johnson, Merck, Novartis and Bayer, alongside regional pioneers including Julphar, Hikma, SPIMACO, Riyadh Pharma, Jamjoom Pharma, Tabuk Pharmaceuticals, and Gulf Pharmaceutical Industries.

A distinctive element of the summit is the active participation of local pharmaceutical authorities and regulatory agencies, offering insight into national priorities, evolving standards and regional market dynamics.

PharmaXcelerate 2026 is where the region’s pharma community connects to shape the future of resilient, high-quality and sustainable manufacturing.

Why this conference? Why now? Why Dubai?

PharmaXcelerate 2026 comes at a pivotal moment as the Middle East rapidly emerges as a global hub for pharmaceutical and biotech manufacturing. Driven by large-scale investments, localization initiatives and Vision 2030 strategies, the region is transitioning from import dependency to advanced production and innovation. Hosting the conference in Dubai brings together global expertise and regional leadership to accelerate this transformation - fostering partnerships, technology transfer and compliance excellence. Now is the time to align international best practices with regional ambitions, ensuring the Middle East becomes a center of resilient, high-quality and sustainable pharmaceutical manufacturing.